Lorraine Myers | Authors


Oncolytic Vaccines With Chemotherapy Show Survival Benefit in Head and Neck Cancer

September 15, 2015

The attenuated vaccinia virus, GL-ONC1, demonstrated safety and clinical benefit when delivered intravenously with concurrent chemoradiation therapy in patients who have locoregionally advanced head and neck carcinoma (LA-HNC).

Multidisciplinary Approach to Radium-223 Treatment Favored for Metastatic Prostate Cancer

September 09, 2015

Radium-223 dichloride (Xofigo) has shown a significant survival advantage in the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) who have symptomatic bone metastases, and a multidisciplinary approach to treatment has become more widely practiced in community clinics.

New Immunotherapy With Chemotherapy Shows Results in Ovarian Cancer

September 09, 2015

A novel immunotherapy, EGEN-001, combined with pegylated liposomal doxorubicin (PLD) has demonstrated clinical benefit in recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer patients.